Roth Capital Starts Fate Therapeutics (FATE) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.17 | 52 Week High | $4.76 | |||
| Open | $2.17 | 52 Week Low | $1.46 | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.12 | EPS | $-1.91 | |||
| Volume | 804,287 | |||||
